NEW YORK (June 17, 2008)—Highly respected genetic researcher Gerard Davis has been named Head of Product Development and Laboratory Operations at Pfizer Animal Genetics. Dr. Davis will have global responsibilities for research and development of all new products in the Pfizer Animal Genetics portfolio.
“Gerard brings a strong background in genomics research, as well as the foresight to identify and develop the next generations of products our customers demand,” says Nigel Evans, vice president of Animal Genetics for Pfizer Animal Health. “His relevant research in beef genomic technologies, as well as the experience gained from co-founding and building a solid and successful genomics company, Genetic Solutions/Catapult Genetics, will be invaluable as we create and develop a market-leading portfolio of DNA marker-based products.”
Prior to joining Pfizer Animal Genetics, Gerard Davis served as chief executive office of Catapult Genetics Pty. Ltd., which resulted from a merger in December 2006 between Genetic Solutions (co-founded in 1998 by Davis and Jay Hetzel) and Catapult Global. In this position he was responsible for research and development of the company's product portfolio, as well as overall business development.
Previously, Davis was employed by Australia's Commonwealth Scientific and Industrial Research Organization, a major research establishment focused on livestock genetics research. He also spent time as a visiting professor at Colorado State University, where he worked on genotype environment interaction in beef cattle and molecular aspects of quantitative genetics.
Davis obtained a Bachelor of Applied Science degree from the University of New South Wales and in 1998 received his Ph.D. from the University of New England. He completed his MBA degree in 2000 at Queensland University of Technology and is also a graduate member of the Australian Institute of Company Directors.
Pfizer Animal Genetics is a business unit of Pfizer Animal Health, a world leader in discovering and developing innovative animal vaccines and prescription medicines. Pfizer Inc. is the world's largest research-based pharmaceutical company.